Cases selected for the AskAnzal weekly PMCPA insight newsletter
A PCT complained a Novartis rep said Exforge was endorsed by the PCT. Evidence suggested a misunderstanding between…
PMCPA case AUTH/2967/8/17 (Consultant v Shire). Allegation: omission of prescribing and obligatory information. Outcome: no breach; matter found…
MINAP complained a sponsored meeting invite implied MINAP Steering Committee involvement/endorsement. Panel found the invitation misleading and not…
PMCPA case AUTH/2354/9/10 (Anonymous v Consilient Health) about promotion of oral contraceptives. The matter was ruled outwith the…
Anonymous pharmacist alleged off-licence CKD promotion of Invokana at a diabetes conference. Panel couldnβt prove what was said…
A UK health professional alleged RoActemra prescribing information in a Guidelines in Practice product review was out of…
Complaint about Sanofiβs flu vaccine ordering communications and a 30% QIVe dose reduction (with QIVr as an alternative).…
A corporate LinkedIn post named brands and an indication for a newly authorised SLIT tablet. PMCPA ruled this…
Kesimpta promo webpage implied unrestricted SMC approval (restriction not in immediate view). A UK HCP banner ad omitted…
Anonymous complaint alleged a Phase 2/3 sarcoma trial flyer in conference bags was pre-licence promotion and inappropriately distributed.…
One real case. One key lesson. Every week β free.